Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Can China Innovate? Degron Aims For First-In-Class TPD Therapies
New Funds For Novel Platform
Jun 10 2022
•
By
Dexter Jie Yan
Degron one of the latest Chinese biotechs devoted to developing innovative drugs • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from China
More from Focus On Asia